Skip to content
Subscriber Only

Shkreli Says Price Increases for Turing Drug Don't Matter

  • Turing CEO is interviewed about costs on Bloomberg TV
  • Company's drug so small `it doesn't affect the system at all'
Video player cover image

The Politics of High Drug Prices

Updated on

Martin Shkreli, whose pharmaceutical company has been criticized for raising the price of a drug by more than 5,000 percent, said the increase barely causes a ripple in the health-care system.

Shkreli’s company, Turing Pharmaceuticals AG, this year raised the price of Daraprim, used by HIV and cancer patients, to $750 a pill from $13.50 a pill. The company gives away or heavily discounts the treatment for many patients, Shkreli said in an interview on Bloomberg TV.